Future Bio-Science Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 29-05-2024
- Paid Up Capital ₹ 1.50 M
as on 29-05-2024
- Company Age 19 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
About Future Bio-Science
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Mukesh Gupta and Navneet Trehan serve as directors at the Company.
- CIN/LLPIN
U74999DL2005PTC133491
- Company No.
133491
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Mar 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
West Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Future Bio-Science Private Limited offer?
Future Bio-Science Private Limited offers a wide range of products and services, including Plastic & Glass Labware, Volumetric Pipette, Laboratory & Lab Equipment, Laboratory Consumables, Industrial Pipe & Tube Fittings, Tube Fittings, Autoclaves, Sterilizers & Incubators, UV Sterilizer and Lamps, Metal, Security & Safety Detectors, Metal Detector.
Who are the key members and board of directors at Future Bio-Science?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukesh Gupta  | Director | 01-Mar-2005 | Current |
| Navneet Trehan | Director | 01-Mar-2005 | Current |
Financial Performance of Future Bio-Science.
Future Bio-Science Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Future Bio-Science?
In 2017, Future Bio-Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Genaxy Bioinnovations Private LimitedActive 10 months 1 dayMukesh Gupta and Navneet Trehan are mutual person
- Trehan's Appointment With Success Private LimitedActive 13 years 7 months
Navneet Trehan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Future Bio-Science?
Unlock and access historical data on people associated with Future Bio-Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Future Bio-Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Future Bio-Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
